Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-26-014691
Filing Date
2026-04-01
Accepted
2026-04-01 16:50:49
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B3 form424b3.htm 424B3 2175708
2 GRAPHIC form424b3_001.jpg GRAPHIC 4839
3 GRAPHIC ex10-69_001.jpg GRAPHIC 251513
4 GRAPHIC ex10-69_002.jpg GRAPHIC 616554
5 GRAPHIC ex10-69_003.jpg GRAPHIC 232249
6 GRAPHIC ex10-69_004.jpg GRAPHIC 361968
7 GRAPHIC ex10-69_005.jpg GRAPHIC 520636
8 GRAPHIC form10-k_001.jpg GRAPHIC 32378
9 GRAPHIC form10-k_002.jpg GRAPHIC 31387
  Complete submission text file 0001493152-26-014691.txt   5003047
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-286662 | Film No.: 26829122
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)